Investigator-initiated clinical trial
Showing 1 - 25 of >10,000
Intraoperative Fluoroscopy Trial (Intraoperative fluoroscopy)
Not yet recruiting
- Intraoperative Fluoroscopy
- Intraoperative fluoroscopy
- (no location specified)
Dec 14, 2022
Immune Thrombocytopenia Trial (Daratumumab Injection)
Not yet recruiting
- Immune Thrombocytopenia
- Daratumumab Injection
- (no location specified)
Sep 28, 2022
Solid Tumor Trial (KSH01 injection)
Not yet recruiting
- Solid Tumor
- KSH01 injection
- (no location specified)
Oct 11, 2022
Non-Alcoholic Fatty Liver Disease Trial in Seoul (GODEX, Placebo)
Enrolling by invitation
- Non-Alcoholic Fatty Liver Disease
- GODEX
- Placebo
-
Seoul, Korea, Republic ofSeoul National University Hospital
Nov 30, 2023
Recurring Glioblastoma Trial in Fujian (Recombinant L-IFN adenovirus injection)
Recruiting
- Recurring Glioblastoma
- Recombinant L-IFN adenovirus injection
-
Fujian, Fujian, ChinaBinhai Hospital of Fujian Medical University
Jun 27, 2023
Cystic Fibrosis, Lung Infection Bacterial Trial (AtbFinder)
Completed
- Cystic Fibrosis
- Lung Infection Bacterial
- AtbFinder
- (no location specified)
Oct 14, 2022
SARS-CoV-2 Infection Trial in Beijing (HH-120 nasal spray 1, HH-120 nasal spray 2, Placebo Comparator 1)
Completed
- SARS-CoV-2 Infection
- HH-120 nasal spray 1
- +3 more
-
Beijing, Beijing, ChinaBeijing Ditan Hospital,Capital Medical University
Mar 1, 2023
Gaucher Disease, Type 1 Trial (quantitative chemical shift imaging (QCSI), Elelyso)
Completed
- Gaucher Disease, Type 1
- quantitative chemical shift imaging (QCSI)
- Elelyso
- (no location specified)
Oct 27, 2022
Obesity, Inflammation Trial in Hellerup (Dapiglutide, Placebo)
Not yet recruiting
- Obesity
- Inflammation
- Dapiglutide
- Placebo
-
Hellerup, DenmarkCenter for Clinical Metabolic Research, Herlev-Gentofte Hospital
Mar 24, 2023
Advanced Solid Tumor, Relapsed/Refractory Lymphoma Trial in Beijing (OVV-01 Injection+IBR900 Cell Injection)
Recruiting
- Advanced Solid Tumor
- Relapsed/Refractory Lymphoma
- OVV-01 Injection+IBR900 Cell Injection
-
Beijing, Beijing, ChinaBeijing Boren Hospital
Mar 4, 2022
Prevention of COVID-19 Caused by SARS-CoV-2 Trial in Chengdu (randomized, double-blinded, -controlled)
Active, not recruiting
- Prevention of COVID-19 Caused by SARS-CoV-2
- randomized, double-blinded, placebo-controlled
-
Chengdu, ChinaWest China Second University Hospital
Jan 9, 2023
Gastric Cancer, Pancreatic Cancer Trial in Fukuoka-shi (Phase I part, Phase II part)
Recruiting
- Gastric Cancer
- Pancreatic Cancer
- Phase I part
- Phase II part
-
Fukuoka-shi, Fukuoka, Fukuoka, JapanKyushu University Hospital
Jun 24, 2022
Thyroid Cancer Trial in Suita (Targeted alpha therapy)
Recruiting
- Thyroid Cancer
- Targeted alpha therapy
-
Suita, JapanOsaka University Hospital
Mar 2, 2022
Colorectal Cancer Trial in Philadelphia (Regorafenib, 5-FU, Leucovorin)
Terminated
- Colorectal Cancer
- Regorafenib
- +2 more
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Jan 10, 2022
COPD Trial in Webster (OnabotulinumtoxinA, Placebo)
Not yet recruiting
- COPD
- OnabotulinumtoxinA
- Placebo
-
Webster, TexasTranquil Clinical Research
Aug 17, 2023
Acute Myeloid Leukemia in Remission Trial in Suita (DSP-7888)
Recruiting
- Acute Myeloid Leukemia in Remission
-
Suita, Osaka, JapanOsaka University
Feb 28, 2021
Chronic Diarrhea Trial in Aalborg, Aarhus (Opium tincture, Placebo)
Recruiting
- Chronic Diarrhea
- Opium tincture
- Placebo
-
Aalborg, Denmark
- +1 more
Jan 10, 2023
Chronic Skin Disease, Vulvar Lichen Sclerosus Trial in Frauenfeld (FotonaSmooth SP® Spectro laser device, Clobetasol propionate
Active, not recruiting
- Chronic Skin Disease
- Vulvar Lichen Sclerosus
- FotonaSmooth SP® Spectro laser device
- Clobetasol propionate 0.05% ointment
-
Frauenfeld, Thurgau, SwitzerlandCantonal Hospital Frauenfeld
Feb 2, 2022
Refractory Solid Tumor Trial in Xiamen (177Lu-DOTA-EB-FAPI radionuclide therapy)
Recruiting
- Refractory Solid Tumor
- 177Lu-DOTA-EB-FAPI radionuclide therapy
-
Xiamen, Fujian, ChinaThe First Affiliated Hospital of Xiamen University
Jul 26, 2023
Leber Congenital Amaurosis Trial in Shanghai (HG004)
Recruiting
- Leber Congenital Amaurosis
- HG004
-
Shanghai, Shanghai, ChinaXinhua Hospital affiliated with Shanghai Jiao Tong UniversitySch
Oct 12, 2023
Ocular Pain Following Bilateral Photorefractive Keratotomy (PRK) Trial in Sioux Falls (TetraLens bandage contact lens, Control
Recruiting
- Ocular Pain Following Bilateral Photorefractive Keratotomy (PRK)
- TetraLens bandage contact lens
- Control Acuvue Oasys Bandage contact Lens
-
Sioux Falls, South DakotaVance Thompson Vision
Oct 12, 2023
Leber Congenital Amaurosis Trial in Shanghai (HG004)
Recruiting
- Leber Congenital Amaurosis
- HG004
-
Shanghai, Shanghai, ChinaXinhua Hospital affiliated with Shanghai Jiao Tong University Sc
Sep 26, 2023
Type 1 Diabetes, Cardiovascular Diseases, Chronic Inflammation Trial in Hellerup (Colchicine 0.5 MG Oral Tablet, Placebo)
Not yet recruiting
- Type 1 Diabetes
- +2 more
- Colchicine 0.5 MG Oral Tablet
- Placebo
-
Hellerup, Capital Region, DenmarkCenter for Clinical Metabolic Research, Gentofte Hospital
Jul 7, 2023
Aortic Valve Stenosis Trial in Netherlands (Transcatheter Aortic Valve Implantation (TAVI))
Recruiting
- Aortic Valve Stenosis
- Transcatheter Aortic Valve Implantation (TAVI)
-
Nijmegen, Gelderland, Netherlands
- +7 more
Jan 17, 2023